GlaxoSmithKlineGSK 
$16.810.41%24h
0.41%24h
Global rank240
Market cap$69.18B
Change 7d0.45%
YTD Performance-
SP500 benchmark
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of GlaxoSmithKline (GSK)
As of January 2025, GlaxoSmithKline has a market cap of $69.18B. This makes GlaxoSmithKline the world's 240th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of GlaxoSmithKline from 1988 to 2024
-
Value:-
Market cap history of GlaxoSmithKline from 1988 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $85.89B | 14.67% |
| 2023 | $74.90B | 0.88% |
| 2022 | $74.25B | -10.52% |
| 2021 | $82.97B | 19.72% |
| 2020 | $69.31B | -24.56% |
| 2019 | $91.88B | 19.30% |
| 2018 | $77.01B | 12.76% |
| 2017 | $68.30B | -15.33% |
| 2016 | $80.67B | 13.77% |
| 2015 | $70.91B | -0.22% |
| 2014 | $71.06B | -14.61% |
| 2013 | $83.23B | 20.71% |
| 2012 | $68.95B | -9.28% |
| 2011 | $76.00B | 18.67% |
| 2010 | $64.04B | -6.03% |
| 2009 | $68.15B | 2.72% |
| 2008 | $66.34B | 0.43% |
| 2007 | $66.05B | -4.84% |
| 2006 | $69.41B | -8.51% |
| 2005 | $75.87B | 20.21% |
| 2004 | $63.11B | -4.53% |
| 2003 | $66.11B | 7.38% |
| 2002 | $61.56B | -30.82% |
| 2001 | $88.99B | -8.84% |
| 2000 | $97.61B | 8.00% |
| 1999 | $90.38B | -15.38% |
| 1998 | $106.80B | 43.61% |
| 1997 | $74.37B | 51.90% |
| 1996 | $48.96B | 3.61% |
| 1995 | $47.26B | 38.22% |
| 1994 | $34.19B | -8.69% |
| 1993 | $37.44B | -8.58% |
| 1992 | $40.96B | -7.03% |
| 1991 | $44.05B | 101.18% |
| 1990 | $21.90B | 8.03% |
| 1989 | $20.27B | 47.00% |
| 1988 | $13.79B | - |
GSK Market Cap Today is $69.18B 0.41% - 20 Jan 2025
View largest stocks by market cap 
